A human mitofusin 2 mutation can cause mitophagic cardiomyopathy
eLife · 2023
DOI: 10.7554/elife.84235 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Antonietta Franco und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pharmacogenomics, Washington University School of Medicine, St Louis, United States. Hauptthemen laut MEDLINE: Cardiomyopathies, Charcot-Marie-Tooth Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Cardiac muscle has the highest mitochondrial density of any human tissue, but mitochondrial dysfunction is not a recognized cause of isolated cardiomyopathy. Here, we determined that the rare mitofusin (MFN) 2 R400Q mutation is 15–20× over-represented in clinical cardiomyopathy, whereas this specific mutation is not reported as a cause of MFN2 mutant-induced peripheral neuropathy, Charcot–Marie–Tooth disease type 2A (CMT2A). Accordingly, we interrogated the enzymatic, biophysical, and functional characteristics of MFN2 Q400 versus wild-type and CMT2A-causing MFN2 mutants. All MFN2 mutants had impaired mitochondrial fusion, the canonical MFN2 function. Compared to MFN2 T105M that lacked catalytic GTPase activity and exhibited normal activation-induced changes in conformation, MFN2 R400Q and M376A had normal GTPase activity with impaired conformational shifting. MFN2 R400Q did not suppress mitochondrial motility, provoke mitochondrial depolarization, or dominantly suppress mitochondrial respiration like MFN2 T105M. By contrast to MFN2 T105M and M376A, MFN2 R400Q was uniquely defective in recruiting Parkin to mitochondria. CRISPR editing of the R400Q mutation into the mouse Mfn2 gene induced perinatal cardiomyopathy with no other organ involvement; knock-in of Mfn2 T105M or M376V did not affect the heart. RNA sequencing and metabolomics of cardiomyopathic Mfn2 Q/Q400 hearts revealed signature abnormalities recapitulating experimental mitophagic cardiomyopathy. Indeed, cultured cardiomyoblasts and in vivo cardiomyocytes expressing MFN2 Q400 had mitophagy defects with increased sensitivity to doxorubicin. MFN2 R400Q is the first known natural mitophagy-defective MFN2 mutant. Its unique profile of dysfunction evokes mitophagic cardiomyopathy, suggesting a mechanism for enrichment in clinical cardiomyopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Pharmacogenomics, Washington University School of Medicine, St Louis, United States.
- Department of Medicine, Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
- Department of Internal Medicine, Divisions of Human Genetics and Cardiovascular Medicine, Ohio State University, Columbus, United States.
- Center for Cardiovascular Genetic Research, University of Texas Health Science Center at Houston, Houston, United States.
- Department of Neurology, Washington University School of Medicine, St. Louis, United States.
- Department of Internal Medicine (Dermatology), Washington University School of Medicine, St. Louis, United States.
ORCID-Profile: Antonietta Franco, Ray E Hershberger, Xiawei Dang, Gerald W Dorn
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
- NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Franco, A., Li, J., Kelly, D. P., Hershberger, R. E., Marian, A. J., Lewis, R. M., Song, M., Dang, X., Schmidt, A. D., Mathyer, M. E., Edwards, J. R., Strong, C. G., & Dorn, G. W. (2023). A human mitofusin 2 mutation can cause mitophagic cardiomyopathy. eLife. https://doi.org/10.7554/elife.84235
Vancouver
Franco A, Li J, Kelly DP, Hershberger RE, Marian AJ, Lewis RM, et al. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy. eLife. 2023. doi:10.7554/elife.84235
BibTeX
@article{Franco2023,
author = {Franco, Antonietta and Li, Jiajia and Kelly, Daniel P and Hershberger, Ray E and Marian, Ali J and Lewis, Renate M and Song, Moshi and Dang, Xiawei and Schmidt, Alina D and Mathyer, Mary E and Edwards, John R and Strong, Cristina de Guzman and Dorn, Gerald W},
title = {A human mitofusin 2 mutation can cause mitophagic cardiomyopathy},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.84235}
}
EUVIMED